contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


axichem-ab-axichem-presents-its-natural-analogue-capsaicin-axivite-together-with-new-marketing-material-in-series-of-webinars

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.

aXichem

aXichem AB (publ), a developer of natural analogue industrial compounds, has published new marketing material describing the features and benefits of its product aXivite, targeting the neutraceutical...

aXichem AB (publ), a developer of natural analogue industrial compounds, has published new marketing material describing the features and benefits of its product aXivite, targeting the neutraceutical and food supplement market. aXIchem will be hosting a series of webinars open for potential customers and industry partners.- Yesterday we had the pleasure to host aXichem's first industry webinar. Since basically all conferences and meetings are cancelled, due to the pandemic, this is an excellent way to meet the market's interest. To support the event we have produced some new marketing material presenting the unique characteristics of the product, says Torsten Helsing, CEO of aXichem.See the new marketing material here <a href="https://www.axichem.com/wp-content/uploads/2020/09/aXichem_aXivite_brochure.pdf">https://www.axichem.com/wp-content/uploads/2020/09/aXichem_aXivite_brochure.pdf</a>aXivite® is an innovative natural analogue capsaicin solution for a wide range of dietary health applications. Capsaicin is well established in science, for use in weight control products and in applications to promote good gut health. Extensive research results prove that aXivite® has positive health benefits, and can improve human health in line with nature. aXivite® can be used in a variety of new applications, as well as a more effective and safer replacement to naturally extracted capsaicin.According to ResearchandMarkets.com (September 2019) the USA nutraceuticals market is accounted to US$ 73,986.0 Mn in 2018 and is expected to grow at a CAGR of 7.1% during the forecast period 2019 - 2027, to account to US$ 138,047.1 Mn by 2027.This press release was submitted by the contact person below on the 25th of September 2020, at 15:30 CET.

aXichem AB: aXichem presents its natural analogue capsaicin aXivite, together with new marketing material, in series of webinars

Stay up to date with our newsletter